NL-OMON34817已完成4 期
Desensitisation of ulcerative colitis patients intolerant for mesalazine treatment. - Desensitisation for mesalazine
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age> 18 years. 2. History of ulcerative colitis (active or in remission). 3. Presumed history of intolerance (diarrhea, urticaria, fever, acute pancreatitis or elevated c-reactive protein) for any 5-ASA drugs. 4. Informed consent
排除标准
- •1. History of intolerance with the following reactions; interstitial nephritis, anaphylactic shock or bullous skin reations.
- •2. Pregnancy or fertile women without adequate anticonception.
- •3. Renal dysfunction (diminished eGFR <40ml/min)
- •4. Poor mental health.
- •5. No informed consent.
- •6. Non compliance.
研究者
相似试验
进行中（未招募）
不适用
Desensitisation of ulcerative colitis patients intolerant for mesalazine treatment. - Desensitisation for mesalazineEUCTR2010-018557-35-NLniversity Medical Center Groningen20
已完成
不适用
Symptom improvement of ulcerative colitis after an induction dose of ustekinumab in Japanese clinical practice, measured using patient-reported outcomesJPRN-UMIN000043753Janssen Pharmaceutical K.K136
招募中
1 期
Study on the treatment of ulcerative colitis in mild to moderate active stage by removing dampnesslcerative colitisITMCTR2000003426Guangdong Provincial Hospital of Chinese Medicine
已完成
不适用
Faecal transplant for the treatment of active ulcerative colitisUlcerative colitisACTRN12613000236796Royal Adelaide Hospital70
已完成
不适用
Histological remission in ulcerative colitis: comparing histological activity indexesUlcerative colitislcerative colitisDigestive SystemISRCTN61139227Radboud University Medical Center (Netherlands)50